YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Dextran-5- (4-ethoxycarbonylphenylazo) salicylic Acid Ester as a Colon-Specific Prodrug of 5-Aminosalicylic Acid

5-아미노살리실산의 結腸標的性 프로드럭 : 덱스트란-5- (4-에톡시카르보닐페닐아조) 살리실산 에스테르

  • Published : 1998.02.01
Download PDF
⟨ Previous Next ⟩

Abstract

Dextran-5-(4-ethoxycarbonylphenylazo)salicylic acid ester(Dextran-5-ESA) was synthesized as a potential colon-specific prodrug of 5-aminosalicylic acid (5-ASA). No free 5-(4-eth oxycarbonylphenylazo) salicylic acid (5-ESA) was detected when the chemical stability of dextran-5-ESA was tested at pH 1.2, or pH 6.8 bath solution, Effects of the degree of substitution (DS) and molecular weight of dextran on the depolymerization by dextranase was investigated. Depolymerization(%) decreased with increasing DS, and was not affected by M.W. of dextran. The extent of prodrug conversion after incubation in the contents of various G.I. Tract segments of rats was evaluated. 5-ASA was released in the cecal contents, but not in the contents of proximal small intestine (PSI) or distal small intestine (DSI). No significant prodrug conversion was observed in the cecal contents of rats pretreated with kanamycin sulfate, which indicated that microbial enzymes were responsible for the cleavage of the prodrug.

Keywords

References

  1. Oral Colon Specific Drug Delivery Kinetic perspectives in colonic drug delivery Mcleod,. A. D.;Tozer, N. T.;Friend, D. R.(Ed.)
  2. Oral Colon Specific Drug Delivery Drug absorption in the colon: A critical review Mrsny, R. J.;Friend, D. R.(Ed.)
  3. Oral Colon Specific Drug Delivery Oral colon-specific drug delivery with emphasis on insulin : A critical review Saffran, M.;Friend, D. R.(Ed.)
  4. Int. J Pharm. v.97 The role of the gastrointestinal microflora in the metabolism of durgs Shamat, M. A.
  5. FEMS Microbiol. Ecol. v.45 Polysaccharide breakdown by mixed populations of human faecal bacteria Englysth, N.;Hay, S.;Mcfarlane, G. T.
  6. Oral Colon Specific Drug Delivery Dextran prodrugs for colonic-specific drug delivery Andrew, D. M.;Friend, D. R.(Ed.)
  7. Int. J. Pharm. v.84 Chondroitin sulfate : a potential biodegradable carrier for conlon-specific drug delivery Rubinstein, A.;Nakar, D.;Sintov, A.
  8. J. Control. Rel. v.26 An evaluation of pectin as a carrier for drug targeting to the colon Ashore, M. Fell, J.;Astwood, D.;Sharma, H.;Woodhead, P.
  9. Arch. Pharm. Chemi. v.92 Dextrans as carriers for drug compounds-realized and potential applications Larsen, C.;Johansen, M.
  10. J. Pharm. Sci. v.83 Glucocorticoid-dextran conjugate as potential prodrugs for colon-specific delivery : Hydrolysis in rat gastrointestinal tract contents McLeod, A. D;Friend, D. R.;Tozer, T. N.
  11. Br. J. Clin. Pharmacol. v.34 Drug therapy of ulcerative colitis Crotty, B.;Jewel, J. P.
  12. Br. Med. J. v.296 Nephrotic syndrome after treatment with 5-aminosalicylic acid Novis, B. H.;Korzets, J.;Chen, P.;Bernheim, J.
  13. Oral Colon Specific Drug Delivery Low-molecular-weight azo compounds Ryde, E. M.;Friend, D. R.(Ed.)
  14. J. Med. Chem. v.26 A poly Omeric drug for treatment of influammatory bowel disease Brown, J. P.;McGarraugh, G. V.;Parkinson, T. M.;Wingard, R. E.;Onderdonk, A. B.
  15. Makromol. Chem. v.191 Release of 5-aminosalicylic acid from bioadhesive N-(2-hydroxypropyl) emthacrylamide copolymers by azoreductases in vitro Kopeckova, P.;Kopecek, J.
  16. J. Med. Chem. v.36 Brush-border-enzyme-mediated intestine-specific drug delivery. Amino acid prodrugs of 5-aminosalicylic acid Pellicciari, R.;Garzon-Aburbeh, Nathalini, B.;Marinozzi, M.
  17. Magy Kem. FOLY. v.97 Glycosides of 5-Aminosalicylic acid Istran, C.;Gabor, S.;Ferene, S.
  18. J. Pharm. Sci. v.78 no.3 A simple and rapid chromatographic method for the determination of major metabolites of sulfasalazine in biological fluids Chungi, V. S.;Rekhi, G. S.;Shargel, L.
  19. 약학회지 5-아미노살리실산의 결장표적성 prodrug : 5-아미노살리실-L-글루타민산과 5-아미노살리실-L-아스파틸산의 합성과 성상 정연진;이정수;김학현;김영미;한석규
  20. Biopharmaceutical evaluation of salicylazosulfanilic acid as a novel colon-targeted prodrug of 5-aminosalicylic acid v.2 Yamaguchi, T.;Sasaki, K.;Nakayama, T.;Kimura, T.
  21. Can. J. Chem. v.66 A novel method of complete activation by carbonyldiimidazole : application to ester synthesis Robert, C. M.;Gerhard, E. G.
  22. Scand. J. Gastroenterol v.26 Fermentation to short-chain fatty acids and lactate in human faecal batch cultures Mortensen, P. B.;Hove, H.;Clausen, M. R.;Holtug, K.